CoChat

Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities

Open access

The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.

Abstract

STATs are constitutively activated in several malignancies. In primary mediastinal large B-cell lymphoma and Hodgkin lymphoma (HL), inactivating mutations in SOCS1, an inhibitor of JAK/STAT signaling, contribute to deregulated STAT activity. Based on indications that the SOCS1 mutations are caused by the B cell-specific somatic hypermutation (SHM) process, we analyzed B-cell non-HL and normal B cells for mutations in SOCS1. One-fourth of diffuse large B-cell lymphoma and follicular lymphomas carried SOCS1 mutations, which were preferentially targeted to SHM hotspot motifs and frequently obviously inactivating. Rare mutations were observed in Burkitt lymphoma, plasmacytoma, and mantle cell lymphoma but not in tumors of a non-B-cell origin. Mutations in single-sorted germinal center B cells were infrequent relative to other genes mutated as byproducts of normal SHM, indicating that SOCS1 inactivation in primary mediastinal large B-cell lymphoma, HL, diffuse large B-cell lymphoma, and follicular lymphoma is frequently the result of aberrant SHM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2009-06-225839

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 124

Metadata

Authors
Mottok, A., Renné, C., Seifert, M., Oppermann, E., Bechstein, W., Hansmann, M.-L., Küppers, R., & Bräuninger, A.
Affiliations
  • Goethe University Frankfurt (DE)
  • University of Duisburg-Essen (DE)
Venue
Blood
Published
2009-11-12
Volume
114
Issue
20
Pages
4503-4506
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2024790681
Cited by
124
References
26
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 3 · 2021: 8 · 2020: 10 · 2019: 10 · 2018: 11 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 7 · 2013: 5 · 2012: 12
FWCI
6.06
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
somatic hypermutation, B-cell lymphoma, JAK/STAT signaling, primary mediastinal B-cell lymphoma, Hodgkin's disease, diffuse large B-cell lymphoma, follicular lymphoma, germinal center B cells, STAT activation
MeSH terms
Suppressor of Cytokine Signaling 1 Protein, Humans, Mutation, Polymerase Chain Reaction, Lymphoma, B-Cell, Somatic Hypermutation, Immunoglobulin, Suppressor of Cytokine Signaling Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. https://app.cochat.ai/papers/10.1182/blood-2009-06-225839
The paper
Mottok, A., Renné, C., Seifert, M., Oppermann, E., Bechstein, W., Hansmann, M.-L., Küppers, R., & Bräuninger, A. (2009). Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood. https://doi.org/10.1182/blood-2009-06-225839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.